Background
Rising methicillin-resistant
Staphylococcus aureus
(MRSA) poses a global health threat, contributing to serious infections with high mortality rates. Integrons are recognized as significant genetic elements in disseminating multidrug-resistant (MDR) strains. This study focuses on assessing the prevalence of integron classes 1, 2, and 3 in
S. aureus
strains from four major cities in Iran.
Methods
This cross-sectional study analyzed 183
S. aureus
isolates from Shiraz, Tehran, Isfahan, and Yazd in Iran. The isolates were identified using specific biochemical and molecullar tests. The Kirby-Bauer disc diffusion method and microbroth dilution method were employed to determine the susceptibility of the isolates to relevant antibiotics and vancomycin, respectively. The macrolide-lincosamide-streptogramin B (MLS
B
) resistance phenotype was also evaluated using the D-test. All isolates were sought for presence of the
intI
1,
intI
2, and
intI
3 genes.
Results
Among 183
S. aureus
isolates, high resistance rates were noted: 86.3% for erythromycin, 66.1% for ciprofloxacin, and 61.7% for clindamycin, while all isolates were susceptible to linezolid and vancomycin. Of the 183 isolates, 59.6% were identified as MRSA and 78.1% as MDR. According to the D-test results, 112/183 (61.2%), 29/183 (15.8%), 25/183 (13.7%), and 17/183 (9.7%) of
S. aureus
isolates showed constitutive resistance-MLS
B
, inducible resistance-MLS
B
, sensitive, and resistance to macrolide-streptogramin B (MS) phenotypes, respectively. The
intI
1 gene was found in 14 out of 183
S. aureus
isolates (7.6%), while none were positive for the
intI
2 or
intI
3 genes. Notably, 11/14 (78.5%) and 13/14 (92.8%)
intI
1-positive isolates were MRSA and MDR, respectively.
Conclusions
The distribution of MRSA and MDR
S. aureus
isolates in Iran seems concerning. Although the prevalence of
intI
1 was not as high as in prior studies, almost all
S. aureus
harbored the
intI
1 gene were MRSA and MDR.